Literature DB >> 23677997

Hydrolysis of extracellular ATP by ectonucleoside triphosphate diphosphohydrolase (ENTPD) establishes the set point for fibrotic activity of cardiac fibroblasts.

David Lu1, Paul A Insel.   

Abstract

The establishment of set points for cellular activities is essential in regulating homeostasis. Here, we demonstrate key determinants of the fibrogenic set point of cardiac fibroblasts (CFs) by focusing on the pro-fibrotic activity of ATP, which is released by CFs. We tested the hypothesis that the hydrolysis of extracellular ATP by ectonucleoside triphosphate diphosphohydrolases (ENTPDs) regulates pro-fibrotic nucleotide signaling. We detected two ENTPD isoforms, ENTPD-1 and -2, in adult rat ventricular CFs. Partial knockdown of ENTPD-1 and -2 with siRNA increased basal extracellular ATP concentration and enhanced the pro-fibrotic effect of ATP stimulation. Sodium polyoxotungstate-1, an ENTPD inhibitor, not only enhanced the pro-fibrotic effects of exogenously added ATP but also increased basal expression of α-smooth muscle actin, plasminogen activator inhibitor-1 and transforming growth factor (TGF)-β, collagen synthesis, and gel contraction. Furthermore, we found that adenosine, a product of ATP hydrolysis by ENTPD, acts via A2B receptors to counterbalance the pro-fibrotic response to ATP. Removal of extracellular adenosine or inhibition of A2B receptors enhanced pro-fibrotic ATP signaling. Together, these results demonstrate the contribution of basally released ATP in establishing the set point for fibrotic activity in adult rat CFs and identify a key role for the modulation of this activity by hydrolysis of released ATP by ENTPDs. These findings also imply that cellular homeostasis and fibrotic response involve the integration of signaling that is pro-fibrotic by ATP and anti-fibrotic by adenosine and that is regulated by ENTPDs.

Entities:  

Keywords:  ATPases; Adenosine Receptor; ENTPD; Fibroblast; Myofibroblast; P2Y; Purinergic Receptor

Mesh:

Substances:

Year:  2013        PMID: 23677997      PMCID: PMC3696677          DOI: 10.1074/jbc.M113.466102

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

1.  Transgenic over expression of ectonucleotide triphosphate diphosphohydrolase-1 protects against murine myocardial ischemic injury.

Authors:  Ming Cai; Zachary M Huttinger; Heng He; Weizhi Zhang; Feng Li; Lauren A Goodman; Debra G Wheeler; Lawrence J Druhan; Jay L Zweier; Karen M Dwyer; Guanglong He; Anthony J F d'Apice; Simon C Robson; Peter J Cowan; Richard J Gumina
Journal:  J Mol Cell Cardiol       Date:  2011-09-12       Impact factor: 5.000

Review 2.  Structural and functional characterisation of cardiac fibroblasts.

Authors:  Patrizia Camelliti; Thomas K Borg; Peter Kohl
Journal:  Cardiovasc Res       Date:  2005-01-01       Impact factor: 10.787

3.  Electrotonic coupling between human atrial myocytes and fibroblasts alters myocyte excitability and repolarization.

Authors:  Mary M Maleckar; Joseph L Greenstein; Wayne R Giles; Natalia A Trayanova
Journal:  Biophys J       Date:  2009-10-21       Impact factor: 4.033

Review 4.  Origins of cardiac fibroblasts.

Authors:  Elisabeth M Zeisberg; Raghu Kalluri
Journal:  Circ Res       Date:  2010-11-26       Impact factor: 17.367

5.  Identification and characterization of CD39/vascular ATP diphosphohydrolase.

Authors:  E Kaczmarek; K Koziak; J Sévigny; J B Siegel; J Anrather; A R Beaudoin; F H Bach; S C Robson
Journal:  J Biol Chem       Date:  1996-12-20       Impact factor: 5.157

Review 6.  Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function.

Authors:  Francis G Spinale
Journal:  Physiol Rev       Date:  2007-10       Impact factor: 37.312

7.  NTPDase1 (CD39) controls nucleotide-dependent vasoconstriction in mouse.

Authors:  Gilles Kauffenstein; Annick Drouin; Nathalie Thorin-Trescases; Hélène Bachelard; Bernard Robaye; Pedro D'Orléans-Juste; François Marceau; Eric Thorin; Jean Sévigny
Journal:  Cardiovasc Res       Date:  2010-01-01       Impact factor: 10.787

8.  Ecto-nucleoside triphosphate diphosphohydrolase 1 (E-NTPDase1/CD39) regulates neutrophil chemotaxis by hydrolyzing released ATP to adenosine.

Authors:  Ross Corriden; Yu Chen; Yoshiaki Inoue; Guido Beldi; Simon C Robson; Paul A Insel; Wolfgang G Junger
Journal:  J Biol Chem       Date:  2008-08-18       Impact factor: 5.157

9.  Activation of extracellular signal-regulated kinase by stretch-induced injury in astrocytes involves extracellular ATP and P2 purinergic receptors.

Authors:  Joseph T Neary; Yuan Kang; Karen A Willoughby; Earl F Ellis
Journal:  J Neurosci       Date:  2003-03-15       Impact factor: 6.167

Review 10.  Mesoangioblasts--vascular progenitors for extravascular mesodermal tissues.

Authors:  Giulio Cossu; Paolo Bianco
Journal:  Curr Opin Genet Dev       Date:  2003-10       Impact factor: 5.578

View more
  16 in total

Review 1.  Cellular mechanisms of tissue fibrosis. 6. Purinergic signaling and response in fibroblasts and tissue fibrosis.

Authors:  David Lu; Paul A Insel
Journal:  Am J Physiol Cell Physiol       Date:  2013-12-18       Impact factor: 4.249

Review 2.  Cardiac purinergic signalling in health and disease.

Authors:  Geoffrey Burnstock; Amir Pelleg
Journal:  Purinergic Signal       Date:  2014-12-20       Impact factor: 3.765

Review 3.  Mechanisms of epithelial wound detection.

Authors:  Balázs Enyedi; Philipp Niethammer
Journal:  Trends Cell Biol       Date:  2015-03-24       Impact factor: 20.808

4.  Adenosine A2a Receptor Blockade Diminishes Wnt/β-Catenin Signaling in a Murine Model of Bleomycin-Induced Dermal Fibrosis.

Authors:  Jin Zhang; Carmen Corciulo; Hailing Liu; Tuere Wilder; Mayumi Ito; Bruce Cronstein
Journal:  Am J Pathol       Date:  2017-06-28       Impact factor: 4.307

5.  Ectonucleotidase CD39-driven control of postinfarction myocardial repair and rupture.

Authors:  Nadia R Sutton; Takanori Hayasaki; Matthew C Hyman; Anuli C Anyanwu; Hui Liao; Danica Petrovic-Djergovic; Linda Badri; Amy E Baek; Natalie Walker; Keigo Fukase; Yogendra Kanthi; Scott H Visovatti; Ellen L Horste; Jessica J Ray; Sascha N Goonewardena; David J Pinsky
Journal:  JCI Insight       Date:  2017-01-12

6.  Cardiac myocyte-secreted cAMP exerts paracrine action via adenosine receptor activation.

Authors:  Yassine Sassi; Andrea Ahles; Dong-Jiunn Jeffery Truong; Younis Baqi; Sang-Yong Lee; Britta Husse; Jean-Sébastien Hulot; Ariana Foinquinos; Thomas Thum; Christa E Müller; Andreas Dendorfer; Bernhard Laggerbauer; Stefan Engelhardt
Journal:  J Clin Invest       Date:  2014-11-17       Impact factor: 14.808

Review 7.  Purinergic signaling in scarring.

Authors:  Davide Ferrari; Roberto Gambari; Marco Idzko; Tobias Müller; Cristina Albanesi; Saveria Pastore; Gaetano La Manna; Simon C Robson; Bruce Cronstein
Journal:  FASEB J       Date:  2015-09-02       Impact factor: 5.191

8.  Cell-subtype-specific changes in adenosine pathways in schizophrenia.

Authors:  Sinead Marie O'Donovan; Courtney Sullivan; Rachael Koene; Emily Devine; Kathryn Hasselfeld; Cassidy Lynn Moody; Robert Erne McCullumsmith
Journal:  Neuropsychopharmacology       Date:  2018-02-26       Impact factor: 7.853

9.  Stimulation of Adenosine A2B Receptor Inhibits Endothelin-1-Induced Cardiac Fibroblast Proliferation and α-Smooth Muscle Actin Synthesis Through the cAMP/Epac/PI3K/Akt-Signaling Pathway.

Authors:  Sarawuth Phosri; Ajaree Arieyawong; Kwanchai Bunrukchai; Warisara Parichatikanond; Akiyuki Nishimura; Motohiro Nishida; Supachoke Mangmool
Journal:  Front Pharmacol       Date:  2017-06-30       Impact factor: 5.810

10.  Acute In Vivo Analysis of ATP Release in Rat Kidneys in Response to Changes of Renal Perfusion Pressure.

Authors:  Oleg Palygin; Louise C Evans; Allen W Cowley; Alexander Staruschenko
Journal:  J Am Heart Assoc       Date:  2017-09-12       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.